切换导航
  • 比较产品
我的购物车

StemSpan™T细胞祖细胞成熟补充剂（10X）

补充淋巴样祖细胞成熟为T细胞
率先评论此产品
添加并比较

产品号 #（选择产品）

产品号 #09930_C

补充淋巴样祖细胞成熟为T细胞

main product photo
总览
实验数据
产品说明书及文档
应用领域
相关材料与文献
相关产品

概述

使用StemSpan™T细胞祖细胞成熟补充剂（10X）支持淋巴样祖细胞成熟为双阳性（DP） T细胞。

为了您的方便，本补充可单独或作为一部分StemSpan™T细胞生成试剂盒或者是STEMdiff™T细胞检测试剂盒。在这个方案中，CD34+细胞首先分化为CD7+CD5+淋巴祖细胞，使用StemSpan™淋巴祖细胞扩增补品（10X），然后进一步分化为DP T细胞。

StemSpan™T细胞祖细胞成熟补充剂（10X）用于联合使用StemSpan™SFEM II介质，并在印版上涂布StemSpan™淋巴细胞分化涂层材料（100X）。它还支持DP T细胞在额外刺激下向CD8 T细胞成熟。

有关CD34扩增和分化的详细信息+干细胞与StemSpan™，请浏览技术手册和教育材料.

Subtype
Supplements
 
Cell Type
Hematopoietic Stem and Progenitor Cells
 
Species
Human
 
Application
Cell Culture, Differentiation
 
Brand
StemSpan
 
Area of Interest
Cancer, Immunology, Stem Cell Biology, Cell Therapy Development
 
Formulation Category
Serum-Free
 

查看更多 显示更少

Data Figures

Figure 1. Frequency and Yield of CD7+CD5+ Pro-T Cells After 14 Days of Culture

CB-derived CD34+ cells (freshly isolated or frozen) were cultured for 14 days in StemSpan™ SFEM II containing Lymphoid Progenitor Expansion Supplement (Catalog #09915) on plates coated with Lymphoid Differentiation Coating Material (Catalog #09925). Cells were harvested and analyzed for CD7 and CD5 expression by (A) flow cytometry. The (B) average frequency of viable CD7+CD5+ pro-T cells on day 14 was 70%, with ~200 CD7+CD5+ cells produced per input CD34+ cell. Shown are means with 95% confidence intervals (n = 33).

Figure 2. Frequency and Yield of CD4 ISP and CD4+CD8+ DP Cells After 42 Days of Culture

CB-derived CD34+ cells (freshly isolated or frozen) were cultured with the StemSpan™ T Cell Generation Kit (Catalog #09940) for 42 days and (A) analysed by flow cytometry for the expression of CD4, CD8, CD3 and TCRαβ. The (B) frequency and (C) yield of CD4 ISP, double-positive (CD4+CD8+) and CD3+TCRαβ+-expressing double-positive cells (CD4+CD8+CD3+TCRαβ+) are shown. On average, 38% of the total viable population were DP (CD4+CD8+), of which 35% co-expressed CD3 and TCRαβ. The yields of total DP cells and CD3+TCRαβ+ DP cells per input CD34+ cell were ~23,000 and ~9,000, respectively. Shown are means with 95% confidence intervals (n = 31).

Figure 3. Frequency and Yield of CD8 SP T Cells After 49 Days of Culture

DP cells were further matured into CD8 SP T cells by culturing for an additional 7 days in StemSpan™ SFEM II with T Cell Progenitor Maturation Supplement (Catalog #09930), IL-15 (Catalog #78031) and ImmunoCult™ CD3/CD28/CD2 T Cell Activator (Catalog #10970) on coated plates. On day 49, cells were (A) analyzed by flow cytometry for the expression of CD3, TCRαβ, CD4 and CD8. The (B) frequency and yield of CD3+TCRαβ+-expressing cells and their subsets are shown. On average, 54% of the CD3+TCRαβ+ cells were DP (CD4+CD8+) and 38% were CD8 SP (CD4-CD8+). The average yield of CD8 SP T cells per input CD34+ cell was ~6,000. CD3+TCRαβ+ CD4 SP (CD4+CD8-) T cells were detected at very low frequencies (data not shown). Shown are means with 95% confidence intervals (n = 12).

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Information Sheet
Product Name
StemSpan™ T Cell Progenitor Maturation Supplement (10X)
Catalog #
09930
Lot #
All
Language
English
Document Type
Technical Manual
Product Name
StemSpan™ T Cell Progenitor Maturation Supplement (10X)
Catalog #
09930
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
StemSpan™ T Cell Progenitor Maturation Supplement (10X)
Catalog #
09930
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Research Area
Workflow Stages

更多信息

更多信息
Species Human
Formulation Category Serum-Free
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。